SMARCA4 p.18

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS1

The NM_001123066.4(MAPT):​c.1535C>A​(p.Pro512His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000571 in 1,576,748 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P512S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000048 ( 1 hom. )

Consequence

MAPT
NM_001123066.4 missense

Scores

1
3
13

Clinical Significance

Likely benign criteria provided, single submitter U:1B:1

Conservation

PhyloP100: 2.55

Publications

0 publications found
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
MAPT Gene-Disease associations (from GenCC):
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • semantic dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • supranuclear palsy, progressive, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • late-onset Parkinson disease
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • progressive supranuclear palsy-parkinsonism syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12812608).
BP6
Variant 17-45993951-C-A is Benign according to our data. Variant chr17-45993951-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 2498709.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000144 (22/152294) while in subpopulation AMR AF = 0.000718 (11/15310). AF 95% confidence interval is 0.000402. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001123066.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPT
NM_001377265.1
MANE Select
c.1732+2365C>A
intron
N/ANP_001364194.1A0A7I2PJZ2
MAPT
NM_001123066.4
c.1535C>Ap.Pro512His
missense
Exon 10 of 15NP_001116538.2P10636-9
MAPT
NM_016835.5
c.1507+2365C>A
intron
N/ANP_058519.3P10636-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPT
ENST00000262410.10
TSL:1 MANE Select
c.1732+2365C>A
intron
N/AENSP00000262410.6A0A7I2PJZ2
MAPT
ENST00000344290.10
TSL:1
c.1534+2365C>A
intron
N/AENSP00000340820.6A0A7I2PLE3
MAPT
ENST00000351559.10
TSL:1
c.556+2365C>A
intron
N/AENSP00000303214.7P10636-8

Frequencies

GnomAD3 genomes
AF:
0.000145
AC:
22
AN:
152176
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000719
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000574
AC:
11
AN:
191580
AF XY:
0.0000581
show subpopulations
Gnomad AFR exome
AF:
0.0000925
Gnomad AMR exome
AF:
0.000140
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000741
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000477
AC:
68
AN:
1424454
Hom.:
1
Cov.:
32
AF XY:
0.0000482
AC XY:
34
AN XY:
705180
show subpopulations
African (AFR)
AF:
0.0000307
AC:
1
AN:
32580
American (AMR)
AF:
0.000127
AC:
5
AN:
39488
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25512
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37746
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81176
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50786
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5716
European-Non Finnish (NFE)
AF:
0.0000439
AC:
48
AN:
1092514
Other (OTH)
AF:
0.000221
AC:
13
AN:
58936
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000144
AC:
22
AN:
152294
Hom.:
0
Cov.:
33
AF XY:
0.000175
AC XY:
13
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41556
American (AMR)
AF:
0.000718
AC:
11
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68016
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000486
Hom.:
0
Bravo
AF:
0.000193

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
MAPT-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
13
DANN
Uncertain
1.0
Eigen
Benign
0.13
Eigen_PC
Benign
0.049
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.44
T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.1
T
PhyloP100
2.5
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.081
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.078
T
gMVP
0.16
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs192236920; hg19: chr17-44071317; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.